Evidence map›Paper›PMID 28108469›Full record

ArticleDisease models & mechanisms2017

Blood RNA biomarkers in prodromal PARK4 and rapid eye movement sleep behavior disorder show role of complexin 1 loss for risk of Parkinson's disease.

Suna Lahut, Suzana Gispert, Özgür Ömür, Candan Depboylu, Kay Seidel, Jorge Antolio Domínguez-Bautista, Nadine Brehm, Hülya Tireli, Karl Hackmann, Caroline Pirkevi and 20 more

Open access · goldAbstract read
In one paragraph

Article in Disease models & mechanisms, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Differential blood DNA methylation across Lewy body dementias.Alzheimer's & dementia (Amsterdam, Netherlands) · 2021
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 11 institutions in 3 countries.

Suna LahutExperimental Neurology, Goethe University Medical School, Frankfurt/Main 60590, Germany.ORCID 0000-0003-3320-6825
Suzana GispertExperimental Neurology, Goethe University Medical School, Frankfurt/Main 60590, Germany.
Özgür ÖmürExperimental Neurology, Goethe University Medical School, Frankfurt/Main 60590, Germany.
Candan DepboyluDepartment of Neurology, Philipps University, Baldingerstrasse, Marburg 35043, Germany.
Kay SeidelDr Senckenberg Chronomedical Institute, Goethe University, Frankfurt/Main 60590, Germany.
Jorge Antolio Domínguez-BautistaExperimental Neurology, Goethe University Medical School, Frankfurt/Main 60590, Germany.
Nadine BrehmExperimental Neurology, Goethe University Medical School, Frankfurt/Main 60590, Germany.
Hülya TireliDepartment of Neurology, Haydarpaşa Numune Training and Research Hospital, Istanbul 34668, Turkey.ORCID 0000-0002-1830-514X
Karl HackmannInstitute for Clinical Genetics, Faculty of Medicine Carl Gustav Carus, TU Dresden, Fetscherstrasse 74, Dresden 01307, Germany.
Caroline PirkeviNDAL, Boğaziçi University, Istanbul 34342, Turkey.ORCID 0000-0002-7958-631X
Barbara LeubeInstitute of Human Genetics, Heinrich Heine University, Düsseldorf 40225, Germany.
Vincent RiesDepartment of Neurology, Philipps University, Baldingerstrasse, Marburg 35043, Germany.
Kerstin ReimDepartment of Molecular Neurobiology and Center for the Molecular Physiology of the Brain, Max Planck Institute of Experimental Medicine, Göttingen 37075, Germany.
Nils BroseDepartment of Molecular Neurobiology and Center for the Molecular Physiology of the Brain, Max Planck Institute of Experimental Medicine, Göttingen 37075, Germany.
Wilfred F den DunnenDepartment of Pathology and Medical Biology, Medical Center, University, Groningen 9700 RB, The Netherlands.
Madrid JohnsonBuchmann Institute for Molecular Life Sciences and Institute for Biophysics, Goethe University, Frankfurt/Main 60438, Germany.
Zsuzsanna WolfHaemophilia Centre, Medical Clinic III, Institute of Immunohaematology and Transfusion Medicine, Goethe University, Frankfurt/Main 60590, Germany.ORCID 0000-0003-2682-7340
Marc SchindewolfDepartment of Internal Medicine, Division of Vascular Medicine and Hemostaseology, Goethe University, Frankfurt 60590, Germany.
Wiebke SchrempfDivision of Neurodegenerative Diseases, Department of Neurology, Technische Universität, Dresden 01307, Germany.
Kathrin ReetzDepartment of Neurology, RWTH Aachen University Hospital, Aachen 52074, Germany.
Peter YoungDepartment of Sleep Medicine and Neuromuscular Disorders, University Hospital Münster, Münster 48149, Germany.
David VadaszDepartment of Neurology, Philipps University, Baldingerstrasse, Marburg 35043, Germany.
Achilleas S FrangakisBuchmann Institute for Molecular Life Sciences and Institute for Biophysics, Goethe University, Frankfurt/Main 60438, Germany.
Evelin SchröckInstitute for Clinical Genetics, Faculty of Medicine Carl Gustav Carus, TU Dresden, Fetscherstrasse 74, Dresden 01307, Germany.
Helmuth SteinmetzExperimental Neurology, Goethe University Medical School, Frankfurt/Main 60590, Germany.
Marina JendrachExperimental Neurology, Goethe University Medical School, Frankfurt/Main 60590, Germany.
Udo RübDr Senckenberg Chronomedical Institute, Goethe University, Frankfurt/Main 60590, Germany.
Ayşe Nazlı BaşakNDAL, Boğaziçi University, Istanbul 34342, Turkey.
Wolfgang OertelDepartment of Neurology, Philipps University, Baldingerstrasse, Marburg 35043, Germany.
Georg AuburgerExperimental Neurology, Goethe University Medical School, Frankfurt/Main 60590, Germany auburger@em.uni-frankfurt.de.ORCID 0000-0001-7355-2701
Goethe University Frankfurt · DEPhilipps University of Marburg · DEBoğaziçi University · TRMax Planck Institute of Experimental Medicine · DEUniversity Hospital Carl Gustav Carus · DEGerman Center for Neurodegenerative Diseases · DEHaydarpaşa Numune Eğitim ve Araştırma Hastanesi · TRHeinrich Heine University Düsseldorf · DEUniversitätsklinikum Aachen · DEUniversity Hospital Münster · DEUniversity Medical Center Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parkinson's disease (PD) is a frequent neurodegenerative process in old age. Accumulation and aggregation of the lipid-binding SNARE complex component α-synuclein (SNCA) underlies this vulnerability and defines stages of disease progression. Determinants of SNCA levels and mechanisms of SNCA neurotoxicity have been intensely investigated. In view of the physiological roles of SNCA in blood to modulate vesicle release, we studied blood samples from a new large pedigree with

Indexed as

Genetic Predisposition to DiseaseAdaptor Proteins, Vesicular Transportalpha-SynucleinBiomarkersFemaleHeterozygoteHumansLewy Body DiseaseMiddle AgedNerve Tissue ProteinsParkinson DiseaseReal-Time Polymerase Chain ReactionREM Sleep Behavior DisorderRNARNA, MessengerAdaptor Proteins, Vesicular Transportalpha-SynucleinBiomarkerscomplexin INerve Tissue ProteinsRNARNA, MessengerBiomarkersComplexin 1PARK4Parkinson's diseaseRapid eye movement sleep behavior disorderα-synuclein

Identifiers

PMID28108469
PMCPMC5451169
OpenAlexW2579122492

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.